Trust Point Inc. Has $237,000 Stake in CME Group Inc. (NASDAQ:CME)

Trust Point Inc. grew its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 7.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,021 shares of the financial services provider’s stock after purchasing an additional 72 shares during the period. Trust Point Inc.’s holdings in CME Group were worth $237,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Truvestments Capital LLC purchased a new position in shares of CME Group during the third quarter valued at approximately $26,000. SJS Investment Consulting Inc. lifted its stake in CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 97 shares in the last quarter. Dunhill Financial LLC boosted its holdings in CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 81 shares during the last quarter. Financial Life Planners bought a new stake in shares of CME Group in the 4th quarter worth $32,000. Finally, Fortitude Family Office LLC raised its holdings in shares of CME Group by 120.3% in the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 83 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

CME Group Stock Performance

Shares of CME stock opened at $244.41 on Friday. The firm’s 50 day moving average is $235.20 and its 200 day moving average is $223.49. The stock has a market capitalization of $88.08 billion, a P/E ratio of 25.70, a PEG ratio of 5.37 and a beta of 0.57. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $249.02. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group announced that its Board of Directors has initiated a share repurchase program on Thursday, December 5th that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the financial services provider to buy up to 3.4% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board believes its stock is undervalued.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be issued a $1.25 dividend. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a dividend yield of 2.05%. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

Analyst Ratings Changes

Several research analysts recently weighed in on CME shares. Oppenheimer boosted their price target on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Keefe, Bruyette & Woods reduced their target price on CME Group from $260.00 to $256.00 and set a “market perform” rating for the company in a report on Monday, January 13th. Morgan Stanley increased their price target on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research report on Thursday, October 17th. Deutsche Bank Aktiengesellschaft cut their price objective on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Finally, Citigroup lowered CME Group from a “buy” rating to a “neutral” rating and decreased their target price for the company from $255.00 to $250.00 in a research report on Monday, January 6th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus price target of $229.27.

Read Our Latest Stock Report on CME

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.